EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokoll

Effect of immune checkpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in locally advanced gastric cancer: study protocol of a single-center, randomised clinical trial

Da Zhou, Qingchuan Chen, Zichen Liu, Rui Xu, Shuomeng Xiao, Fazhi Zhao, Chao Yang, Weiyang He, Xiang Zhou, Zhi Ding, Ping Zhao, Xiaodong Chen

Contemporary Clinical Trials · 2026-11 · 170 · 108464

DOI: 10.1016/j.cct.2026.108464 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2026-11. Verfasst von Da Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Ca…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neoadjuvant Therapy, Immune Checkpoint Inhibitors. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program, National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In recent years, immune checkpoint inhibitors have played a crucial role in neoadjuvant treatment of gastric cancer, but their efficacy still needs to be improved. Immunonutrition not only reduces the incidence of malnutrition but also enhances the tolerance to neoadjuvant treatment and strengthens the immune function, making it a potential immunotherapy sensitizing agent. Therefore, this study aimed to explore whether immunonutrition therapy could enhance the efficacy of gastric cancer immunotherapy by reshaping the tumor immune microenvironment, providing new ideas and schemes for the neoadjuvant therapy of locally advanced gastric cancer (LAGC). METHODS: This study is a pragmatic, open label, single-center randomised controlled study. Suitable LAGC patients were screened and randomly assigned in a 1:1 ratio to the control group - neoadjuvant chemotherapy (NAC) and the intervention group - neoadjuvant chemotherapy combined with immunotherapy and oral immunonutrition (NACII). The primary endpoint is pathological complete response after 3 cycle treatment. The following secondary endpoints will be evaluated: R0 resection rate; lymph node status after neoadjuvant therapy; The safety of the treatment plan. The accompanying changes in the immune status and tumor microenvironment is set as the exploratory endpoint. 76 LAGC at least is expected to include in this study. DISCUSSION: The present study is the first prospective trial to evaluate the effectiveness of immunocheckpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in LAGC. This trial may provide valuable insights for enhancing immunotherapy and establish new strategies for the neoadjuvant treatment of LAGC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsNeoadjuvant TherapyImmune Checkpoint InhibitorsHumansImmunonutrition DietTumor MicroenvironmentRandomized Controlled Trials as TopicPathologic Complete ResponseImmunotherapyProspective StudiesFemaleMale

Stichwörter der Autor:innen

Gastric cancerImmunocheckpoint inhibitorsImmunonutritionImmunotherapyNeoadjuvant therapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Gastric Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of Ch…
  • Department of Gastric Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Cheng…

Förderung

  • Sichuan Provincial Science and Technology Support Program
  • National Science and Technology Major Project

Zitieren

APA

Zhou, D., Chen, Q., Liu, Z., Xu, R., Xiao, S., Zhao, F., Yang, C., He, W., Zhou, X., Ding, Z., Zhao, P., & Chen, X. (2026). Effect of immune checkpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in locally advanced gastric cancer: study protocol of a single-center, randomised clinical trial. Contemporary Clinical Trials, 170, 108464. https://doi.org/10.1016/j.cct.2026.108464

Vancouver

Zhou D, Chen Q, Liu Z, Xu R, Xiao S, Zhao F, et al. Effect of immune checkpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in locally advanced gastric cancer: study protocol of a single-center, randomised clinical trial. Contemporary Clinical Trials. 2026;170:108464. doi:10.1016/j.cct.2026.108464

BibTeX
@article{Zhou2026,
  author = {Zhou, Da and Chen, Qingchuan and Liu, Zichen and Xu, Rui and Xiao, Shuomeng and Zhao, Fazhi and Yang, Chao and He, Weiyang and Zhou, Xiang and Ding, Zhi and Zhao, Ping and Chen, Xiaodong},
  title = {Effect of immune checkpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in locally advanced gastric cancer: study protocol of a single-center, randomised clinical trial},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  volume = {170},
  pages = {108464},
  doi = {10.1016/j.cct.2026.108464}
}
Kostenlos starten →